Does the Diffusion Profile Differ Between Botulinum Toxin Type a Formulations? Implications for the Management of Post-Stroke Spasticity
Botulinum toxin type A is a first-line treatment for post-stroke spasticity, with selective action at nerve endings and minimal effects beyond the injection site. However, concerns about potential adverse reactions due to toxin diffusion and spread can significantly influence physicians’ therapeutic...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2024-11-01
|
| Col·lecció: | Toxins |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2072-6651/16/11/480 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|